Many small biotech players have put the foot on the gas in 2020. With the urgent need for a COVID-19 vaccine and treatment …
Shares in Athersys, Inc. (ATHX) soared more than 20% in U.
The chaos gripping global markets is showing no signs of abating just yet, with the major indexes bleeding heavenly at the start of …
Shares of Athersys (ATHX) are skyrocketing today, up 19% in pre-market trading, after the clinical-stage biotech announced encouraging summary results from its exploratory …
Athersys, Inc. (NASDAQ:ATHX) announced the pricing of its previously announced underwritten public offering of 19,802,000 shares of its common stock, par value $0.
Athersys, Inc. (NASDAQ:ATHX) investors cheer the announcement that the stem cell company received Special Protocol Assessment (SPA) from the FDA for the design and planned analysis …
Athersys, Inc. (NASDAQ:ATHX) announced he successful completion of Japan’s Pharmaceutical and Medical Devices Agency (PMDA) review of the Clinical Trial Notification (CTN), allowing …
Athersys, Inc. (NASDAQ:ATHX) announced its financial results for the three months ended June 30, 2016.
Wall Street analysts weighed in today on beauty products retailer Ulta Salon Cosmetics & Fragrance Inc.(NASDAQ:ULTA) and biotech firm Athersys, Inc.
Athersys, Inc. (NASDAQ:ATHX) announced its financial results for the fourth quarter and year ended December 31, 2015.
